DPP4 and type 2 diabetes mellitus: Specifically, in patients with type II diabetes, inhibiting dipeptidyl peptidase‐4 (DPP4), an enzyme that cleaves X‐proline dipeptides from the N‐terminus of polypeptides, using the DPP4 inhibitor linagliptin, led to changes in numerous urinary peptides.